» Authors » Yoichi Tanaka

Yoichi Tanaka

Explore the profile of Yoichi Tanaka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 177
Citations 1620
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Desai K, Tanaka Y, Angadi P, Kheur S, Puranik U, Tatsumi A, et al.
Odontology . 2024 Jul; 113(1):438-447. PMID: 38951299
Odontogenic keratocysts (OKCs) are locally aggressive cysts that exhibit typical histopathological features and have a propensity for recurrence. Though histological variations are observed in OKCs, hard tissue formation and metaplastic...
2.
Baratta M, Jian W, Hengel S, Kaur S, Cunliffe J, Boer J, et al.
Bioanalysis . 2024 Jun; 16(9):307-364. PMID: 38913185
The 17 Workshop on Recent Issues in Bioanalysis (17 WRIB) took place in Orlando, FL, USA on June 19-23, 2023. Over 1000 professionals representing pharma/biotech companies, CROs, and multiple regulatory...
3.
Kholmanskikh O, Wang Y, Hersey S, Wadhwa M, Block K, Bandukwala A, et al.
Bioanalysis . 2024 Jun; 16(8):179-220. PMID: 38899739
The 17 Workshop on Recent Issues in Bioanalysis (17 WRIB) took place in Orlando, FL, USA on 19-23 June 2023. Over 1000 professionals representing pharma/biotech companies, CROs, and multiple regulatory...
4.
Tanaka Y, Fujii R, Shigetoh H, Sato G, Morioka S
J Pain Res . 2024 May; 17:1929-1940. PMID: 38812822
Purpose: This study aimed to juxtapose the circadian rhythm of pain with the conventional 7-day assessment and ascertain the feasibility of condensing the evaluation of the circadian rhythm of pain...
5.
Adachi K, Ohyama K, Tanaka Y, Murayama N, Shimizu M, Saito Y, et al.
Biol Pharm Bull . 2024 May; 47(5):1028-1032. PMID: 38797695
Omeprazole, a gastric acid pump inhibitor, is repeatedly administered and is oxidatively metabolized mainly by polymorphic cytochrome P450 2C19. The prescribed dosage of omeprazole was discontinued or reduced in 47...
6.
Uragami S, Osumi M, Sumitani M, Fuyuki M, Igawa Y, Iki S, et al.
Phys Ther . 2024 Apr; 104(7). PMID: 38567849
Objective: Pain after a stroke interferes with daily life and the rehabilitation process. This study aimed to clarify the prognosis of pain in subgroups of patients with pain after a...
7.
Adachi K, Ohyama K, Tanaka Y, Saito Y, Shimizu M, Yamazaki H
Biol Pharm Bull . 2024 Mar; 47(3):635-640. PMID: 38494736
Fluvastatin is a 3-hydroxy-3-methylglutaryl CoA reductase inhibitor that competitively inhibits human cytochrome P450 (P450) 2C9 in vitro. Drug interactions between a variety of P450 2C9 substrates/inhibitors and fluvastatin can increase...
8.
Shigetoh H, Koga M, Tanaka Y, Hirakawa Y, Morioka S
Sci Rep . 2024 Feb; 14(1):4873. PMID: 38418550
Central sensitization-related symptoms (CSS) are associated with the severity and progression of pain. The relationship between the severity of pain/CSS and clinical progresses remains unclear. This multicenter, collaborative, longitudinal study...
9.
Mora J, Palmer R, Wagner L, Wu B, Partridge M, Meena , et al.
Bioanalysis . 2024 Feb; 16(7):77-119. PMID: 38389403
The 17 Workshop on Recent Issues in Bioanalysis (17 WRIB) took place in Orlando, FL, USA on June 19-23, 2023. Over 1000 professionals representing pharma/biotech companies, CROs, and multiple regulatory...
10.
Okamoto H, Tanaka Y, Shibagaki Y, Kuronuma S, Miyatani Y, Umeda S, et al.
J Chromatogr B Analyt Technol Biomed Life Sci . 2024 Jan; 1234:123993. PMID: 38246006
Thiopurine is metabolized to 6-thio-(deoxy) guanosine triphosphate (6-thio-(d) GTP), which is then incorporated into DNA or RNA and causes cytotoxicity. Nudix hydrolase 15 (NUDT15) reduces the cytotoxic effects of thiopurine...